1. Audit of febrile neutropenic (FN) episodes in men receiving docetaxel for hormone-sensitive metastatic prostate cancer (HSMPC). (June 2016) Authors: Raby, S.; Mahil, J.; Hughes, C.; Lyons, J.; Patel, K.; Elliott, T.; Conroy, Journal: Clinical oncology Issue: Volume 28(2016)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Febrile Neutropenia Rates in Men Treated with Docetaxel Chemotherapy for Metastatic Hormone-sensitive Prostate Cancer. Issue 9 (September 2016) Authors: Mahil, J.; Hughes, C.; Patel, K.; Lyons, J.; Elliott, P.A.; Choudhury, A.; Conroy, R. Journal: Clinical oncology Issue: Volume 28:Issue 9(2016) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0037: Correlation between coronary artery doses and survival in locally advanced lung cancer patients. (April 2018) Authors: Aznar, M.; Vasquez Osorio, E.; Kennedy, J.; Mahil, J.; Swinton, M.; Faivre-Finn, C.; Van Herk, M.; McWilliam, A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗